Burning Rock Biotech Limited (BNR)
USD 2.79
(-2.79%)
USD 2.79
(-2.79%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 271.59 Million CNY | -36.71% |
| 2022 | 429.12 Million CNY | -0.96% |
| 2021 | 433.27 Million CNY | 79.02% |
| 2020 | 242.02 Million CNY | -86.08% |
| 2019 | 1.73 Billion CNY | 78.16% |
| 2018 | 976.13 Million CNY | 321.03% |
| 2017 | 231.84 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 345.53 Million CNY | 28.89% |
| 2024 Q1 | 268.09 Million CNY | -1.29% |
| 2023 Q2 | 363.14 Million CNY | -2.33% |
| 2023 FY | 271.59 Million CNY | -36.71% |
| 2023 Q4 | 271.59 Million CNY | -10.59% |
| 2023 Q3 | 303.74 Million CNY | -16.36% |
| 2023 Q1 | 371.8 Million CNY | -13.36% |
| 2022 Q4 | 429.12 Million CNY | -0.75% |
| 2022 Q3 | 432.35 Million CNY | 0.77% |
| 2022 Q2 | 429.04 Million CNY | -5.33% |
| 2022 FY | 429.12 Million CNY | -0.96% |
| 2022 Q1 | 453.21 Million CNY | 4.6% |
| 2021 Q2 | 366.11 Million CNY | 4.98% |
| 2021 Q4 | 433.27 Million CNY | 18.67% |
| 2021 FY | 433.27 Million CNY | 79.02% |
| 2021 Q3 | 365.11 Million CNY | -0.27% |
| 2021 Q1 | 348.74 Million CNY | 44.1% |
| 2020 Q1 | 180.78 Million CNY | -89.6% |
| 2020 Q4 | 242.02 Million CNY | -10.34% |
| 2020 Q3 | 269.94 Million CNY | 4.31% |
| 2020 FY | 242.02 Million CNY | -86.08% |
| 2020 Q2 | 258.79 Million CNY | 43.14% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q3 | 167.23 Million CNY | 0.0% |
| 2019 FY | 1.73 Billion CNY | 78.16% |
| 2019 Q4 | 1.73 Billion CNY | 939.91% |
| 2018 Q4 | 380.01 Million CNY | 0.0% |
| 2018 FY | 976.13 Million CNY | 321.03% |
| 2017 FY | 231.84 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -575.163% |
| Biodesix, Inc. | 94.51 Million USD | -187.349% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -7967.945% |
| Castle Biosciences, Inc. | 86.54 Million USD | -213.826% |
| DarioHealth Corp. | 38.24 Million USD | -610.135% |
| Exact Sciences Corporation | 3.32 Billion USD | 91.834% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 84.703% |
| Illumina, Inc. | 4.36 Billion USD | 93.779% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -4753.59% |
| iSpecimen Inc. | 6.07 Million USD | -4368.383% |
| Standard BioTools Inc. | 159.86 Million USD | -69.888% |
| 23andMe Holding Co. | 206.64 Million USD | -31.428% |
| Medpace Holdings, Inc. | 1.09 Billion USD | 75.262% |
| NeoGenomics, Inc. | 739.69 Million USD | 63.283% |
| Inotiv, Inc. | 588.04 Million USD | 53.814% |
| Psychemedics Corporation | 6.59 Million USD | -4016.263% |
| Prenetics Global Limited | 44.01 Million USD | -517.066% |
| Precipio, Inc. | 3.67 Million USD | -7296.269% |
| RadNet, Inc. | 2.07 Billion USD | 86.901% |
| Sotera Health Company | 2.68 Billion USD | 89.891% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -1153.015% |
| Exagen Inc. | 34.25 Million USD | -692.966% |
| Natera, Inc. | 691.79 Million USD | 60.741% |
| Aspira Women's Health Inc. | 8.62 Million USD | -3048.151% |
| Neogen Corporation | 1.44 Billion USD | 81.14% |
| Myriad Genetics, Inc. | 312.9 Million USD | 13.202% |
| ICON Public Limited Company | 7.74 Billion USD | 96.495% |
| Bionano Genomics, Inc. | 118.24 Million USD | -129.681% |
| CareDx, Inc | 223.28 Million USD | -21.633% |
| Check-Cap Ltd. | 1.33 Million USD | -20320.376% |
| Twist Bioscience Corporation | 152.97 Million USD | -77.544% |
| Guardant Health, Inc. | 1.62 Billion USD | 83.315% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -15491.286% |
| Fulgent Genetics, Inc. | 139.82 Million USD | -94.239% |
| Sera Prognostics, Inc. | 25.28 Million USD | -974.204% |
| OPKO Health, Inc. | 622.47 Million USD | 56.369% |
| Personalis, Inc. | 95.65 Million USD | -183.919% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -2993.586% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -1153.015% |
| MDxHealth SA | 121.92 Million USD | -122.754% |
| Prenetics Global Limited | 44.01 Million USD | -517.066% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -24699.275% |
| Mainz Biomed B.V. | 12.15 Million USD | -2133.515% |
| Trinity Biotech plc | 83.38 Million USD | -225.711% |
| Neuronetics, Inc. | 81.64 Million USD | -232.665% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -7967.945% |